Abstract
Iodine123-labeled metaiodobenzylguanidine, a radioiodinated analogue of norepinephrine, is a tracer for evaluating sympathetic function. We used iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy and sympathetic skin response to study autonomic nervous functions in 19 patients with Machado-Joseph disease (MJD) and 20 control subjects. Planar imaging of all the participants was done to evaluate myocardial scintigraphy. The ratio of average counts in the heart to average counts in the mediastinum was calculated for both early and delayed images, the latter of which reflects the cardiac neural uptake of the tracer. Single photon emission computed tomography also was done on 12 patients with MJD to examine regional tracer uptake to the heart. The mean ratio of counts in the heart to counts in the mediastinum in the delayed images was lower for the patients with MJD than for the control subjects (p <0.01). Abnormal sympathetic skin response was present in 6 patients with MJD whose mean ratio of counts in the heart to counts in the mediastinum was lower than that of patients with MJD who had normal sympathetic skin response (p <0.01). A single photon emission computed tomography study showed significantly lower accumulation of the tracer in patients with MJD than in the control subjects in the anterior lateral sectors predominantly innervated by sympathetic nerves but not in the inferior septal sectors reported to be under main innervation by parasympathetic fibers. These results show that MJD is accompanied by cardiac sympathetic dysfunction, as detected by iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy, which appears to be correlated with sudomotor sympathetic dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wieland DM, Brown LE, Rogers WL, Worthington KC, Clinthorne NH, Otto CA, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog.J Nucl Med 1981; 22:22–31.
Nakajo M, Shaprio B, Glowinak J, Sisson JC, Beiermaltes WH. Inverse relationship between cardiac accumulation of meta-[131]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma.J Nucl Med 1983; 24: 1127–1134.
Dae MW, O'Connell W, Botvinick E, Abearn T, Yee E, Huberty JP, et al. Scintigraphic assessment of regional cardiac adrenergic innervation.Circulation 1989; 79:634–644.
Meriet P, Valette H, Dubois-Rand JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.J Nucl Med 1992; 33:471–477.
Mätysaari M, Kuikka J, Mustonen J, Tahvanainam K, Vannien E, Länstmies E, et al. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I] Metaiodobenzyl guanidine.Diabetes 1992; 41:1069–1075.
Sisson JC, Shapiro B, Meyers I, Mallette S, Mangnen TJ, Wieland DM, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.J Nucl Med 1987; 28:1625–1636.
Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.J Neurol Sci 1998; 155:60–67.
Takiyama Y, Sakoe K, Nakano I, Nishizawa M. Machado-Joseph disease: cerebellar ataxia and autonomic dysfunction in a patient with the shortest known expanded allele (56 CAG repeat units) of the MJD1 gene.Neurology 1997; 49:604–606.
Hara H, Sakai T, Koike F. Autonomic dysfunction in Joseph disease.J Auton Nerv Syst 1986; 23:284–288.
Yamamoto M, Kachi T, Sobue G. Pain-related and electrically stimulated somatosensory evoked potentials in patients with Machado-Joseph disease and multiple system atrophy.Intern Med 1997; 36:550–555.
Kazuta T, Hayashi M, Yoshita M, Hirai S. Iodine-123-labeled meta-iodobenzylguanidine myocardial scintigraphy evaluation of Machado-Joseph disease.Clin Neurol (Tokyo) 1998; 38:97–101.
Sollanki KK, Bornanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interferes with the biodistribution of radiolabeled meta-iodobenzylguanidine (MIBG).Nucl Med Commun 1992; 13:513–521.
Nakajima K, Taki J, Tonami N, Hisada K. Decreased 123I-MIBG uptake and increased clearance in various cardiac disease.Nucl Med Comm 1994; 15:317–323.
Gill JS, Hunter GJ, Gane G, Ward DE, Camm AJ. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine-123-labeled metaiodobenzylguanidine scintigraphy.Am Heart J 1993; 126:390–398.
Yokota T, Matsunaga T, Okiyama R, Hirose K, Tanabe H, Furukawa T, et al. Sympathetic skin response in patients with multiple sclerosis compared with patients with spinal cord transection and normal controls.Brain 1991; 114:1381–1394.
Thames MD, Klopfenstein HS, Abboud FM, Mark AAL, Walker JL. Preferential distribution of inhibitory cardiac receptors with vagal afferents to the inferoposterior wall of the left ventricle activated during coronary occlusion in the dog.Circ Res 1978; 43:512–519.
Kinoshita A, Hayashi M, Oda M, Tanabe H. Clinical study of the peripheral nervous system in Machado-Joseph disease.J Neurol Sci 1995; 130:48–58.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kazuta, T., Hayashi, M., Shimizu, T. et al. Autonomic dysfunction in Machado-Joseph disease assessed by iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy. Clinical Autonomic Research 10, 111–115 (2000). https://doi.org/10.1007/BF02278014
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02278014